Platelets and chemokines in atherosclerosis: partners in crime.
about
Chemokines and their receptors in AtherosclerosisA new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient micePlatelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage AtherosclerosisUnveiling the inflammatory face of antiplatelet drugsThe cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker ratsAdenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient miceHigh platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.Endothelial dysfunction and specific inflammation in obesity hypoventilation syndromeRole of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells.Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifePlatelet activity and cardiovascular risk in apparently healthy individuals: a review of the data.Platelets as delivery systems for disease treatmentsChemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.Chemokine receptor CCR5: from AIDS to atherosclerosisMonocyte accumulation in mouse atherogenesis is progressive and proportional to extent of diseaseCa²⁺-dependent nitric oxide release in the injured endothelium of excised rat aorta: a promising mechanism applying in vascular prosthetic devices in aging patients.Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe diseasePotential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.Inflammation in coronary artery disease: potential role for immunomodulatory therapy.Platelets in inflammation and atherogenesis.Cannabinoid receptors in acute and chronic complications of atherosclerosis.Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients.Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice.Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition.Chemokines: inflammatory mediators of atherosclerosis.The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo.Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosisAssociations between arterial stiffness and platelet activation in normotensive overweight and obese young adultsPlatelet chemokines in vascular disease.The role of the endocannabinoid system in atherosclerosis.Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungsEmerging hematological targets and therapy for cardiovascular disease: From bench to bedsideA genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: a randomized controlled trial.
P2860
Q26801787-85326174-BB58-4787-92A5-EA6F02F901B6Q27302261-82468960-8A3E-4C7D-AE7A-EAD9A8246531Q27329947-9A2F4BC7-69B7-458C-95B2-507977D33DEFQ27339951-7C19DCCB-6007-4BB1-BCB5-1BBD7BF252ABQ28199397-8A725C97-9272-47E3-8A4B-4C64AD76F27CQ28579415-25960CA0-261A-4C74-AE13-47F19D9361E9Q30432457-63515C89-DFD1-4889-B6BB-FDEAE8AB7D32Q30450312-1F4F3370-966F-4250-AB7F-50271B16B427Q30497499-F5322C13-04C6-4687-B557-47F8E7466351Q33375217-EC21ACAC-3008-4BD6-A4E8-DC9C267185C5Q33496141-40F659F5-7FA9-4C67-8D60-D80D8910D026Q33546380-9D9E752D-9C2F-494F-82FD-57A0CA441D13Q33735189-CCB741B0-7336-46C2-A07B-928EC23C65B1Q33896059-6C85AA46-08DC-4567-B552-6D152C992B22Q34348837-994B9EAD-5E61-4476-AEF5-BF78D677DBABQ34430115-4F8C44C5-51A0-4A5C-92EF-BEA92DBE774DQ34672038-F326A2D7-9BF2-4DD7-9A66-4A666CC8214CQ34772143-29F7C7D0-73A2-42AA-BA03-AA82A6FA712EQ35050904-2F3BE941-81CC-4945-9E22-AF1EA0236A97Q35215601-8A6F44CF-84E5-4163-BB21-3E08817B02D0Q35907475-5778DECB-9893-4890-A83C-5E5A4E0C2DC2Q36127490-6F3D1034-341F-48CF-9A11-9B0EFF6013F8Q36283698-8A564B81-F705-4D6D-BCA1-60F8D5384D63Q36314881-F7FA874E-DA53-4A41-AA39-D550D1384EC4Q36328825-B52852DA-F556-47FC-8528-69899C325541Q36416368-354E114F-0645-4790-9D55-53CF870E0669Q36460761-E3F62671-F896-4B71-8B85-95847EF1CD3FQ36482911-F6D4FC10-FA46-4640-9D77-592A70B48007Q36617730-6E3D1C2A-9264-4E85-99E5-E93A773DB952Q36687945-351CFE80-38CD-407C-ADDB-2B7DC79556B0Q36879940-31C19A8E-C204-4392-9CAB-A4BD119514E1Q37064707-1F67867C-C937-46E4-B777-EAD7CC1E7233Q37080012-0844C5C4-A2EE-4C7D-95EF-B7055DB5591BQ37093386-7D75EABF-0B3C-4EF4-B722-825E857D444AQ37131719-5C05741F-F0B2-4D87-8115-9D05777643EFQ37143578-ADCAAAAD-4241-4130-B2C3-0DE052CAEA4FQ37266020-737D6D7D-0214-4668-9084-FD2B377E18F2Q37290687-D5DE0564-01F0-4FEA-B413-B26CFFE34002Q37432574-AE12C489-817C-4E50-A406-BEA79EDB6D26Q37442700-7BA7C3D2-4ED5-4F2A-A36C-79F1196FF33F
P2860
Platelets and chemokines in atherosclerosis: partners in crime.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Platelets and chemokines in atherosclerosis: partners in crime.
@ast
Platelets and chemokines in atherosclerosis: partners in crime.
@en
type
label
Platelets and chemokines in atherosclerosis: partners in crime.
@ast
Platelets and chemokines in atherosclerosis: partners in crime.
@en
prefLabel
Platelets and chemokines in atherosclerosis: partners in crime.
@ast
Platelets and chemokines in atherosclerosis: partners in crime.
@en
P1433
P1476
Platelets and chemokines in atherosclerosis: partners in crime.
@en
P304
P356
10.1161/01.RES.0000160077.17427.57
P577
2005-04-01T00:00:00Z